25 XP   0   0   10

Alpine Immune Sciences Inc
Buy, Hold or Sell?

Let's analyse Alpine Immune Sciences Inc together

PenkeI guess you are interested in Alpine Immune Sciences Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Alpine Immune Sciences Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Alpine Immune Sciences Inc

I send you an email if I find something interesting about Alpine Immune Sciences Inc.

Quick analysis of Alpine Immune Sciences Inc (30 sec.)










What can you expect buying and holding a share of Alpine Immune Sciences Inc? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
€4.70
Expected worth in 1 year
€6.83
How sure are you?
27.8%

+ What do you gain per year?

Total Gains per Share
€2.13
Return On Investment
3.5%

For what price can you sell your share?

Current Price per Share
€60.00
Expected price per share
€31.60 - €60.50
How sure are you?
50%

1. Valuation of Alpine Immune Sciences Inc (5 min.)




Live pricePrice per Share (EOD)

€60.00

Intrinsic Value Per Share

€-11.17 - €-13.16

Total Value Per Share

€-6.47 - €-8.46

2. Growth of Alpine Immune Sciences Inc (5 min.)




Is Alpine Immune Sciences Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$327.9m$144m$63m30.4%

How much money is Alpine Immune Sciences Inc making?

Current yearPrevious yearGrowGrow %
Making money-$8m-$14.4m$6.3m79.5%
Net Profit Margin-98.0%-308.8%--

How much money comes from the company's main activities?

3. Financial Health of Alpine Immune Sciences Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#167 / 1016

Most Revenue
#258 / 1016

Most Profit
#504 / 1016

Most Efficient
#567 / 1016

What can you expect buying and holding a share of Alpine Immune Sciences Inc? (5 min.)

Welcome investor! Alpine Immune Sciences Inc's management wants to use your money to grow the business. In return you get a share of Alpine Immune Sciences Inc.

What can you expect buying and holding a share of Alpine Immune Sciences Inc?

First you should know what it really means to hold a share of Alpine Immune Sciences Inc. And how you can make/lose money.

Speculation

The Price per Share of Alpine Immune Sciences Inc is €60.00. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Alpine Immune Sciences Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Alpine Immune Sciences Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €4.70. Based on the TTM, the Book Value Change Per Share is €0.53 per quarter. Based on the YOY, the Book Value Change Per Share is €0.21 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Alpine Immune Sciences Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps0.090.2%-0.12-0.2%-0.22-0.4%-0.16-0.3%-0.16-0.3%
Usd Book Value Change Per Share2.544.2%0.570.9%0.220.4%0.280.5%0.280.5%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share2.544.2%0.570.9%0.220.4%0.280.5%0.280.5%
Usd Price Per Share18.52-11.70-7.72-8.62-8.62-
Price to Earnings Ratio50.94-3.50--10.32--9.27--9.27-
Price-to-Total Gains Ratio7.30--1,080.69--74.15--302.40--302.40-
Price to Book Ratio3.70-3.71-3.84-7.88-7.88-
Price-to-Total Gains Ratio7.30--1,080.69--74.15--302.40--302.40-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share63.876
Number of shares15
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.570.28
Usd Total Gains Per Share0.570.28
Gains per Quarter (15 shares)8.504.17
Gains per Year (15 shares)33.9816.67
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1034240177
20685803324
301029205041
4013612606758
5017016008375
60204194010092
702382280117109
802722620133126
903062960150143
1003403300167160

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.03.00.025.0%1.011.00.08.3%1.017.00.05.6%1.017.00.05.6%1.017.00.05.6%
Book Value Change Per Share1.03.00.025.0%3.09.00.025.0%5.013.00.027.8%5.013.00.027.8%5.013.00.027.8%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.018.00.0%0.00.018.00.0%0.00.018.00.0%
Total Gains per Share1.03.00.025.0%3.09.00.025.0%5.013.00.027.8%5.013.00.027.8%5.013.00.027.8%

Fundamentals of Alpine Immune Sciences Inc

About Alpine Immune Sciences Inc

Alpine Immune Sciences, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the discovery and development of immunotherapies through protein engineering technologies for treating autoimmune and inflammatory diseases. The company's product pipeline includes Povetacicept, a dual B cell cytokine antagonist, which is in Phase 2 clinical trial for the treatment of multiple autoimmune and inflammatory diseases; and Acazicolcept, a dual inhibitor of the CD28 and ICOS T cell costimulatory pathways that is in preclinical trial for the treatment of systemic lupus erythematosus. It is also developing RUBY-3 that has completed Phase 1 clinical trial for the treatment of glomerulonephritis; and RUBY-4, which has completed Phase 1 clinical trial for the treatment of cytopenias. The company was incorporated in 2007 and is headquartered in Seattle, Washington.

Fundamental data was last updated by Penke on 2024-04-18 04:43:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is cheap.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Alpine Immune Sciences Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Alpine Immune Sciences Inc earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Alpine Immune Sciences Inc to the Biotechnology industry mean.
  • A Net Profit Margin of 19.3% means that €0.19 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Alpine Immune Sciences Inc:

  • The MRQ is 19.3%. The company is making a huge profit. +2
  • The TTM is -98.0%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ19.3%TTM-98.0%+117.3%
TTM-98.0%YOY-308.8%+210.9%
TTM-98.0%5Y-536.4%+438.4%
5Y-536.4%10Y-536.4%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ19.3%-199.6%+218.9%
TTM-98.0%-213.0%+115.0%
YOY-308.8%-279.3%-29.5%
5Y-536.4%-438.4%-98.0%
10Y-536.4%-605.5%+69.1%
1.1.2. Return on Assets

Shows how efficient Alpine Immune Sciences Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Alpine Immune Sciences Inc to the Biotechnology industry mean.
  • 1.6% Return on Assets means that Alpine Immune Sciences Inc generated €0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Alpine Immune Sciences Inc:

  • The MRQ is 1.6%. Using its assets, the company is less efficient in making profit.
  • The TTM is -3.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ1.6%TTM-3.4%+5.0%
TTM-3.4%YOY-5.7%+2.3%
TTM-3.4%5Y-6.7%+3.3%
5Y-6.7%10Y-6.7%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.6%-13.5%+15.1%
TTM-3.4%-12.9%+9.5%
YOY-5.7%-11.8%+6.1%
5Y-6.7%-14.1%+7.4%
10Y-6.7%-16.0%+9.3%
1.1.3. Return on Equity

Shows how efficient Alpine Immune Sciences Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Alpine Immune Sciences Inc to the Biotechnology industry mean.
  • 1.8% Return on Equity means Alpine Immune Sciences Inc generated €0.02 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Alpine Immune Sciences Inc:

  • The MRQ is 1.8%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is -5.3%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ1.8%TTM-5.3%+7.1%
TTM-5.3%YOY-10.6%+5.4%
TTM-5.3%5Y-16.0%+10.8%
5Y-16.0%10Y-16.0%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.8%-16.9%+18.7%
TTM-5.3%-16.1%+10.8%
YOY-10.6%-15.1%+4.5%
5Y-16.0%-19.9%+3.9%
10Y-16.0%-20.9%+4.9%

1.2. Operating Efficiency of Alpine Immune Sciences Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Alpine Immune Sciences Inc is operating .

  • Measures how much profit Alpine Immune Sciences Inc makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Alpine Immune Sciences Inc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Alpine Immune Sciences Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-45.5%+45.5%
TTM-45.5%YOY-316.3%+270.8%
TTM-45.5%5Y-516.7%+471.2%
5Y-516.7%10Y-516.7%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--295.1%+295.1%
TTM-45.5%-225.8%+180.3%
YOY-316.3%-288.4%-27.9%
5Y-516.7%-477.4%-39.3%
10Y-516.7%-625.6%+108.9%
1.2.2. Operating Ratio

Measures how efficient Alpine Immune Sciences Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.95 means that the operating costs are €0.95 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Alpine Immune Sciences Inc:

  • The MRQ is 0.950. The company is less efficient in keeping operating costs low.
  • The TTM is 2.220. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ0.950TTM2.220-1.271
TTM2.220YOY4.163-1.943
TTM2.2205Y6.543-4.323
5Y6.54310Y6.5430.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9503.090-2.140
TTM2.2203.264-1.044
YOY4.1633.783+0.380
5Y6.5435.679+0.864
10Y6.5437.894-1.351

1.3. Liquidity of Alpine Immune Sciences Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Alpine Immune Sciences Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 7.86 means the company has €7.86 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Alpine Immune Sciences Inc:

  • The MRQ is 7.862. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.759. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ7.862TTM4.759+3.103
TTM4.759YOY3.297+1.461
TTM4.7595Y3.804+0.955
5Y3.80410Y3.8040.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ7.8623.914+3.948
TTM4.7594.220+0.539
YOY3.2975.388-2.091
5Y3.8046.045-2.241
10Y3.8046.406-2.602
1.3.2. Quick Ratio

Measures if Alpine Immune Sciences Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Alpine Immune Sciences Inc to the Biotechnology industry mean.
  • A Quick Ratio of 6.76 means the company can pay off €6.76 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Alpine Immune Sciences Inc:

  • The MRQ is 6.757. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 4.121. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ6.757TTM4.121+2.636
TTM4.121YOY2.502+1.619
TTM4.1215Y2.408+1.713
5Y2.40810Y2.4080.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ6.7573.572+3.185
TTM4.1213.998+0.123
YOY2.5025.390-2.888
5Y2.4085.969-3.561
10Y2.4086.287-3.879

1.4. Solvency of Alpine Immune Sciences Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Alpine Immune Sciences Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Alpine Immune Sciences Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.14 means that Alpine Immune Sciences Inc assets are financed with 13.7% credit (debt) and the remaining percentage (100% - 13.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Alpine Immune Sciences Inc:

  • The MRQ is 0.137. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.287. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.137TTM0.287-0.150
TTM0.287YOY0.449-0.162
TTM0.2875Y0.481-0.194
5Y0.48110Y0.4810.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1370.336-0.199
TTM0.2870.334-0.047
YOY0.4490.269+0.180
5Y0.4810.366+0.115
10Y0.4810.390+0.091
1.4.2. Debt to Equity Ratio

Measures if Alpine Immune Sciences Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Alpine Immune Sciences Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 15.8% means that company has €0.16 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Alpine Immune Sciences Inc:

  • The MRQ is 0.158. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.421. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.158TTM0.421-0.263
TTM0.421YOY0.849-0.427
TTM0.4215Y1.212-0.790
5Y1.21210Y1.2120.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1580.382-0.224
TTM0.4210.396+0.025
YOY0.8490.335+0.514
5Y1.2120.434+0.778
10Y1.2120.465+0.747

2. Market Valuation of Alpine Immune Sciences Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Alpine Immune Sciences Inc generates.

  • Above 15 is considered overpriced but always compare Alpine Immune Sciences Inc to the Biotechnology industry mean.
  • A PE ratio of 50.94 means the investor is paying €50.94 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Alpine Immune Sciences Inc:

  • The EOD is 175.664. Based on the earnings, the company is expensive. -2
  • The MRQ is 50.943. Based on the earnings, the company is expensive. -2
  • The TTM is 3.504. Based on the earnings, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD175.664MRQ50.943+124.721
MRQ50.943TTM3.504+47.438
TTM3.504YOY-10.323+13.828
TTM3.5045Y-9.274+12.779
5Y-9.27410Y-9.2740.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD175.664-2.259+177.923
MRQ50.943-2.569+53.512
TTM3.504-2.664+6.168
YOY-10.323-4.120-6.203
5Y-9.274-6.258-3.016
10Y-9.274-6.171-3.103
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Alpine Immune Sciences Inc:

  • The EOD is -54.858. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -15.909. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -10.208. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-54.858MRQ-15.909-38.949
MRQ-15.909TTM-10.208-5.701
TTM-10.208YOY1.039-11.247
TTM-10.2085Y-5.941-4.266
5Y-5.94110Y-5.9410.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-54.858-2.924-51.934
MRQ-15.909-3.246-12.663
TTM-10.208-3.488-6.720
YOY1.039-5.620+6.659
5Y-5.941-8.315+2.374
10Y-5.941-8.826+2.885
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Alpine Immune Sciences Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 3.70 means the investor is paying €3.70 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Alpine Immune Sciences Inc:

  • The EOD is 12.770. Based on the equity, the company is expensive. -2
  • The MRQ is 3.703. Based on the equity, the company is fair priced.
  • The TTM is 3.713. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD12.770MRQ3.703+9.067
MRQ3.703TTM3.713-0.009
TTM3.713YOY3.840-0.128
TTM3.7135Y7.876-4.163
5Y7.87610Y7.8760.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD12.7701.851+10.919
MRQ3.7032.090+1.613
TTM3.7132.095+1.618
YOY3.8402.844+0.996
5Y7.8763.466+4.410
10Y7.8763.815+4.061
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Alpine Immune Sciences Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--2.3830.532+348%0.210+1037%0.261+813%0.261+813%
Book Value Per Share--4.6982.968+58%2.065+128%1.577+198%1.577+198%
Current Ratio--7.8624.759+65%3.297+138%3.804+107%3.804+107%
Debt To Asset Ratio--0.1370.287-52%0.449-70%0.481-72%0.481-72%
Debt To Equity Ratio--0.1580.421-62%0.849-81%1.212-87%1.212-87%
Dividend Per Share----0%-0%-0%-0%
Eps--0.085-0.115+235%-0.207+342%-0.148+273%-0.148+273%
Free Cash Flow Per Share---0.273-0.285+4%-0.158-42%-0.098-64%-0.098-64%
Free Cash Flow To Equity Per Share--1.9700.341+478%0.210+840%0.295+567%0.295+567%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---13.162--------
Intrinsic Value_10Y_min---11.166--------
Intrinsic Value_1Y_max---0.760--------
Intrinsic Value_1Y_min---0.746--------
Intrinsic Value_3Y_max---2.709--------
Intrinsic Value_3Y_min---2.578--------
Intrinsic Value_5Y_max---5.172--------
Intrinsic Value_5Y_min---4.764--------
Market Cap3933630000.000+71%1140752700.000720427944.375+58%475641427.500+140%531131106.250+115%531131106.250+115%
Net Profit Margin--0.193-0.980+607%-3.088+1699%-5.364+2877%-5.364+2877%
Operating Margin----0.4550%-3.1630%-5.1670%-5.1670%
Operating Ratio--0.9502.220-57%4.163-77%6.543-85%6.543-85%
Pb Ratio12.770+71%3.7033.7130%3.840-4%7.876-53%7.876-53%
Pe Ratio175.664+71%50.9433.504+1354%-10.323+120%-9.274+118%-9.274+118%
Price Per Share60.000+71%17.40010.989+58%7.255+140%8.101+115%8.101+115%
Price To Free Cash Flow Ratio-54.858-245%-15.909-10.208-36%1.039-1631%-5.941-63%-5.941-63%
Price To Total Gains Ratio25.181+71%7.302-1080.686+14899%-74.145+1115%-302.403+4241%-302.403+4241%
Quick Ratio--6.7574.121+64%2.502+170%2.408+181%2.408+181%
Return On Assets--0.016-0.034+316%-0.057+462%-0.067+530%-0.067+530%
Return On Equity--0.018-0.053+389%-0.106+685%-0.160+983%-0.160+983%
Total Gains Per Share--2.3830.532+348%0.210+1037%0.261+813%0.261+813%
Usd Book Value--327934041.092207121354.792+58%144094942.240+128%110040220.453+198%110040220.453+198%
Usd Book Value Change Per Share--2.5370.566+348%0.223+1037%0.278+813%0.278+813%
Usd Book Value Per Share--5.0023.159+58%2.198+128%1.678+198%1.678+198%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps--0.091-0.122+235%-0.220+342%-0.157+273%-0.157+273%
Usd Free Cash Flow---19084595.016-19874328.258+4%-11041265.699-42%-6097037.285-68%-6097037.285-68%
Usd Free Cash Flow Per Share---0.291-0.303+4%-0.168-42%-0.105-64%-0.105-64%
Usd Free Cash Flow To Equity Per Share--2.0980.363+478%0.223+840%0.314+567%0.314+567%
Usd Market Cap4187742498.000+71%1214445324.420766967589.582+58%506367863.717+140%565442175.714+115%565442175.714+115%
Usd Price Per Share63.876+71%18.52411.699+58%7.724+140%8.625+115%8.625+115%
Usd Profit--5959873.529-8045829.264+235%-14440193.573+342%-10323892.033+273%-10323892.033+273%
Usd Revenue--30852345.29914718687.663+110%7515840.510+310%6827132.903+352%6827132.903+352%
Usd Total Gains Per Share--2.5370.566+348%0.223+1037%0.278+813%0.278+813%
 EOD+5 -3MRQTTM+30 -2YOY+27 -55Y+27 -510Y+27 -5

3.2. Fundamental Score

Let's check the fundamental score of Alpine Immune Sciences Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15175.664
Price to Book Ratio (EOD)Between0-112.770
Net Profit Margin (MRQ)Greater than00.193
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than16.757
Current Ratio (MRQ)Greater than17.862
Debt to Asset Ratio (MRQ)Less than10.137
Debt to Equity Ratio (MRQ)Less than10.158
Return on Equity (MRQ)Greater than0.150.018
Return on Assets (MRQ)Greater than0.050.016
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Alpine Immune Sciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5079.504
Ma 20Greater thanMa 5043.530
Ma 50Greater thanMa 10035.548
Ma 100Greater thanMa 20026.055
OpenGreater thanClose59.500
Total4/5 (80.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Income before Tax  -17,2044,743-12,461103-12,3571,347-11,01016,7055,695
Net Income  -17,7195,258-12,461103-12,3571,347-11,01016,6095,598
Operating Income  -19,1334,487-14,646-59-14,7051,038-13,66715,1201,453
Total Other Income Expense Net -233-2120-1-58-59530471
Net Income from Continuing Operations  -17,7195,258-12,461103-12,3571,347-11,01016,6095,598



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets379,852
Total Liabilities51,911
Total Stockholder Equity327,941
 As reported
Total Liabilities 51,911
Total Stockholder Equity+ 327,941
Total Assets = 379,852

Assets

Total Assets379,852
Total Current Assets330,034
Long-term Assets49,818
Total Current Assets
Cash And Cash Equivalents 43,921
Short-term Investments 283,491
Net Receivables 167
Total Current Assets  (as reported)330,034
Total Current Assets  (calculated)327,579
+/- 2,455
Long-term Assets
Property Plant Equipment 8,994
Long Term Investments 40,556
Long-term Assets Other 268
Long-term Assets  (as reported)49,818
Long-term Assets  (calculated)49,818
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities41,980
Long-term Liabilities9,931
Total Stockholder Equity327,941
Total Current Liabilities
Accounts payable 3,593
Total Current Liabilities  (as reported)41,980
Total Current Liabilities  (calculated)3,593
+/- 38,387
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt9,914
Long-term Liabilities  (as reported)9,931
Long-term Liabilities  (calculated)9,914
+/- 17
Total Stockholder Equity
Total Stockholder Equity (as reported)327,941
Total Stockholder Equity (calculated)0
+/- 327,941
Other
Capital Stock60
Common Stock Shares Outstanding 60,347
Net Invested Capital 327,941
Net Working Capital 288,054
Property Plant and Equipment Gross 11,827



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-30
> Total Assets 
64,739
54,093
49,849
102,695
154,033
144,090
129,977
159,818
233,480
255,900
233,938
215,826
291,599
286,686
262,100
252,836
240,547
379,852
379,852240,547252,836262,100286,686291,599215,826233,938255,900233,480159,818129,977144,090154,033102,69549,84954,09364,739
   > Total Current Assets 
52,454
42,302
38,088
91,236
142,550
107,101
100,482
139,736
183,749
192,013
176,096
172,289
253,239
240,993
198,784
207,321
197,415
330,034
330,034197,415207,321198,784240,993253,239172,289176,096192,013183,749139,736100,482107,101142,55091,23638,08842,30252,454
       Cash And Cash Equivalents 
17,395
16,123
24,446
88,220
141,075
34,959
12,629
18,813
76,099
67,907
34,889
24,360
126,625
13,376
14,465
34,076
18,981
43,921
43,92118,98134,07614,46513,376126,62524,36034,88967,90776,09918,81312,62934,959141,07588,22024,44616,12317,395
       Short-term Investments 
29,193
24,397
11,237
1,998
0
70,622
84,185
72,247
104,529
94,396
136,980
143,500
122,237
224,265
180,460
169,724
174,472
283,491
283,491174,472169,724180,460224,265122,237143,500136,98094,396104,52972,24784,18570,62201,99811,23724,39729,193
       Net Receivables 
4,851
686
1,036
63
297
388
317
45,343
554
25,323
453
1,638
677
709
668
284
219
167
1672192846687096771,63845325,32355445,343317388297631,0366864,851
       Other Current Assets 
403
721
963
580
341
517
2,571
2,816
1,827
3,667
3,071
2,298
2,723
1,881
0
0
0
0
00001,8812,7232,2983,0713,6671,8272,8162,571517341580963721403
   > Long-term Assets 
12,285
11,791
11,761
11,459
11,483
36,989
29,495
20,082
49,731
63,887
57,842
43,537
38,360
45,693
63,316
45,515
43,132
49,818
49,81843,13245,51563,31645,69338,36043,53757,84263,88749,73120,08229,49536,98911,48311,45911,76111,79112,285
       Property Plant Equipment 
12,031
11,537
11,507
11,205
11,229
11,186
10,925
10,645
10,352
10,553
10,419
10,135
9,989
9,803
9,740
9,549
9,230
8,994
8,9949,2309,5499,7409,8039,98910,13510,41910,55310,35210,64510,92511,18611,22911,20511,50711,53712,031
       Long Term Investments 
0
0
0
0
0
25,549
18,316
9,120
39,064
52,866
46,948
33,041
28,016
35,481
53,170
35,561
33,502
40,556
40,55633,50235,56153,17035,48128,01633,04146,94852,86639,0649,12018,31625,54900000
       Other Assets 
254
254
254
254
254
254
254
317
315
468
475
361
355
409
0
405
0
0
004050409355361475468315317254254254254254254254
> Total Liabilities 
29,908
24,619
24,990
86,467
86,565
81,932
76,683
115,987
110,655
134,997
118,511
116,290
109,590
107,266
92,557
83,448
78,916
51,911
51,91178,91683,44892,557107,266109,590116,290118,511134,997110,655115,98776,68381,93286,56586,46724,99024,61929,908
   > Total Current Liabilities 
13,672
8,681
5,105
28,179
35,849
41,167
43,367
60,246
63,933
69,778
68,165
62,618
68,459
57,996
57,089
53,410
51,818
41,980
41,98051,81853,41057,08957,99668,45962,61868,16569,77863,93360,24643,36741,16735,84928,1795,1058,68113,672
       Short Long Term Debt 
0
418
1,742
119
1,318
2,526
3,742
4,567
4,594
4,622
4,652
4,682
4,547
3,380
2,206
0
0
0
0002,2063,3804,5474,6824,6524,6224,5944,5673,7422,5261,3181191,7424180
       Accounts payable 
5,778
1,543
468
548
742
582
466
1,393
1,839
3,349
1,903
1,812
3,240
4,286
1,662
1,645
3,068
3,593
3,5933,0681,6451,6624,2863,2401,8121,9033,3491,8391,3934665827425484681,5435,778
       Other Current Liabilities 
2,069
1,435
344
23,688
28,505
31,627
34,522
49,151
48,551
51,900
52,012
44,724
47,421
37,418
0
37,252
0
0
0037,252037,41847,42144,72452,01251,90048,55149,15134,52231,62728,50523,6883441,4352,069
   > Long-term Liabilities 
16,236
15,938
19,885
58,288
50,716
40,765
33,316
55,741
46,722
65,219
50,346
53,672
41,131
49,270
35,468
30,038
27,098
9,931
9,93127,09830,03835,46849,27041,13153,67250,34665,21946,72255,74133,31640,76550,71658,28819,88515,93816,236
       Long term Debt 
4,886
4,509
8,169
9,873
8,741
7,602
6,458
5,707
4,547
3,380
2,206
1,025
0
0
0
0
0
0
0000001,0252,2063,3804,5475,7076,4587,6028,7419,8738,1694,5094,886
       Capital Lease Obligations Min Short Term Debt
11,350
11,429
11,716
11,947
12,206
12,470
12,292
12,128
11,961
11,626
11,441
11,246
11,046
10,841
10,622
10,392
10,156
9,914
9,91410,15610,39210,62210,84111,04611,24611,44111,62611,96112,12812,29212,47012,20611,94711,71611,42911,350
       Other Liabilities 
0
0
0
36,468
29,988
21,348
15,250
38,621
30,961
50,830
37,346
42,083
30,803
39,185
0
20,475
0
0
0020,475039,18530,80342,08337,34650,83030,96138,62115,25021,34829,98836,468000
> Total Stockholder Equity
34,831
29,474
24,859
16,228
67,468
62,158
53,294
43,831
122,825
120,903
115,427
99,536
182,009
179,420
169,543
169,388
161,631
327,941
327,941161,631169,388169,543179,420182,00999,536115,427120,903122,82543,83153,29462,15867,46816,22824,85929,47434,831
   Common Stock
19
19
19
19
24
24
24
24
29
30
30
30
44
46
0
49
0
0
004904644303030292424242419191919
   Retained Earnings Total Equity000000000000000000
   Accumulated Other Comprehensive Income 000000000000000000
   Capital Surplus 000000000000000000
   Treasury Stock000000000000000000
   Other Stockholders Equity 
7
10
-118
-55
-41
53
33
45
15
-273
-1,061
-1,369
-1,669
-1,121
0
-650
0
0
00-6500-1,121-1,669-1,369-1,061-27315453353-41-55-118107



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue58,876
Cost of Revenue--
Gross Profit-58,876
 
Operating Income (+$)
Gross Profit-
Operating Expense-103,126
Operating Income-44,250-103,126
 
Operating Expense (+$)
Research Development80,904
Selling General Administrative22,222
Selling And Marketing Expenses-
Operating Expense103,126103,126
 
Net Interest Income (+$)
Interest Income11,852
Interest Expense-98
Other Finance Cost-0
Net Interest Income11,754
 
Pretax Income (+$)
Operating Income-44,250
Net Interest Income11,754
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-32,081-44,665
EBIT - interestExpense = -98
-32,184
-32,086
Interest Expense98
Earnings Before Interest and Taxes (EBIT)--31,983
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-32,081
Tax Provision-103
Net Income From Continuing Ops-32,184-32,184
Net Income-32,184
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net415-11,754
 

Technical Analysis of Alpine Immune Sciences Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Alpine Immune Sciences Inc. The general trend of Alpine Immune Sciences Inc is BULLISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Alpine Immune Sciences Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (100.0%) Bearish trend (-100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Alpine Immune Sciences Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 60.50.

The bearish price targets are: 38.20 > 31.60 > 31.60.

Tweet this
Alpine Immune Sciences Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Alpine Immune Sciences Inc. The current mas is .

The long score for the Moving Averages is 14/14.
The longshort score for the Moving Averages is 14/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Alpine Immune Sciences Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Alpine Immune Sciences Inc. The current macd is 7.5147371.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Alpine Immune Sciences Inc price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Alpine Immune Sciences Inc. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Alpine Immune Sciences Inc price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Alpine Immune Sciences Inc Daily Moving Average Convergence/Divergence (MACD) ChartAlpine Immune Sciences Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Alpine Immune Sciences Inc. The current adx is 47.04.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Alpine Immune Sciences Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Alpine Immune Sciences Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Alpine Immune Sciences Inc. The current sar is 37.39.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Alpine Immune Sciences Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Alpine Immune Sciences Inc. The current rsi is 79.50. The current phase is Overbought in bull market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 0/(-13 +13).

  • Overbought in bull market: Short-term excessive buying, potential for pullback. Consider taking profits, be cautious of potential correction. -1
  • Trending up: The RSI is trending up. +1
Alpine Immune Sciences Inc Daily Relative Strength Index (RSI) ChartAlpine Immune Sciences Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Alpine Immune Sciences Inc. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Alpine Immune Sciences Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Alpine Immune Sciences Inc Daily Stochastic Oscillator ChartAlpine Immune Sciences Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Alpine Immune Sciences Inc. The current cci is 96.50.

Alpine Immune Sciences Inc Daily Commodity Channel Index (CCI) ChartAlpine Immune Sciences Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Alpine Immune Sciences Inc. The current cmo is 62.50.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Alpine Immune Sciences Inc Daily Chande Momentum Oscillator (CMO) ChartAlpine Immune Sciences Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Alpine Immune Sciences Inc. The current willr is -1.73010381.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Alpine Immune Sciences Inc Daily Williams %R ChartAlpine Immune Sciences Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Alpine Immune Sciences Inc.

Alpine Immune Sciences Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Alpine Immune Sciences Inc. The current atr is 2.35200202.

Alpine Immune Sciences Inc Daily Average True Range (ATR) ChartAlpine Immune Sciences Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Alpine Immune Sciences Inc. The current obv is 8,358.

Alpine Immune Sciences Inc Daily On-Balance Volume (OBV) ChartAlpine Immune Sciences Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Alpine Immune Sciences Inc. The current mfi is 55.49.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Alpine Immune Sciences Inc Daily Money Flow Index (MFI) ChartAlpine Immune Sciences Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Alpine Immune Sciences Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-28 00:00:00RSI SHORT ENTRY LONG CLOSE70 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-29 00:00:00CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-11-30 00:00:00CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-01 00:00:00CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-05 00:00:00WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-06 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-07 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-11 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-12 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-14 00:00:00BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-15 00:00:00MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-19 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-21 00:00:00RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-22 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-28 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-29 00:00:00RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-01-02 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-04 00:00:00ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-05 00:00:00CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-08 00:00:00ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-09 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-10 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-11 00:00:00SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-16 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-19 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-22 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-24 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-25 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-26 00:00:00WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-09 00:00:00MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-12 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-13 00:00:00MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-14 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-15 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-19 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-20 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-23 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-28 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04 00:00:00CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-06 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-07 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-08 00:00:00ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-11 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-18 00:00:00RSI SHORT ENTRY LONG CLOSE70 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-19 00:00:00SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-21 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22 00:00:00ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-25 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-03-27 00:00:00CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-28 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-02 00:00:00CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-03 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-04 00:00:00CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-05 00:00:00SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-08 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-10 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-11 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-15 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-16 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-18 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-19 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Alpine Immune Sciences Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Alpine Immune Sciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5079.504
Ma 20Greater thanMa 5043.530
Ma 50Greater thanMa 10035.548
Ma 100Greater thanMa 20026.055
OpenGreater thanClose59.500
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Alpine Immune Sciences Inc with someone you think should read this too:
  • Are you bullish or bearish on Alpine Immune Sciences Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Alpine Immune Sciences Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Alpine Immune Sciences Inc

I send you an email if I find something interesting about Alpine Immune Sciences Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Alpine Immune Sciences Inc.

Receive notifications about Alpine Immune Sciences Inc in your mailbox!